These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30071741)

  • 1. Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
    Li J; Wang T; Jin B; Li W; Wang Z; Zhang H; Song Y; Li N
    Int J Biol Markers; 2018 Nov; 33(4):353-363. PubMed ID: 30071741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu XF; Hu ZD; Liu XC; Cao Y; Ding CM; Hu CJ
    Clin Biochem; 2014 Feb; 47(3):196-200. PubMed ID: 24362268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
    Jia X; Liu J; Gao Y; Huang Y; Du Z
    Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
    Xu C; Yan Z; Zhou L; Wang Y
    J Cancer Res Clin Oncol; 2013 Aug; 139(8):1417-24. PubMed ID: 23743582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis accuracy of serum Glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysis.
    Liu JW; Zuo XL; Wang S
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3655-73. PubMed ID: 26502856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
    Yu J; Wang ZJ; Chen LH; Dong WZ
    Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis.
    Zhang J; Shao C; Zhou Q; Zhu Y; Zhu J; Tu C
    Mol Clin Oncol; 2015 Sep; 3(5):1165-1171. PubMed ID: 26623071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis.
    Qin Z; Yao J; Xu L; Xu Z; Ge Y; Zhou L; Zhao F; Jia R
    Int Braz J Urol; 2020; 46(5):691-704. PubMed ID: 31961625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Tang J; Zhou X; Zhu SL; Li LQ
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1071. PubMed ID: 31777190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
    Sun T; Tang Y; Sun D; Bu Q; Li P
    Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.
    Yang J; Li J; Dai W; Wang F; Shen M; Chen K; Cheng P; Zhang Y; Wang C; Zhu R; Zhang H; Zheng Y; Wang J; Xia Y; Lu J; Zhou Y; Guo C
    Exp Ther Med; 2015 Apr; 9(4):1413-1420. PubMed ID: 25780444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.
    Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z
    Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.
    Xu D; Su C; Sun L; Gao Y; Li Y
    Ann Hepatol; 2019; 18(1):58-67. PubMed ID: 31113610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
    Huang TS; Shyu YC; Turner R; Chen HY; Chen PJ
    Syst Rev; 2013 Jun; 2():37. PubMed ID: 23738605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis.
    Zhu R; Yang J; Xu L; Dai W; Wang F; Shen M; Zhang Y; Zhang H; Chen K; Cheng P; Wang C; Zheng Y; Li J; Lu J; Zhou Y; Wu D; Guo C
    Gastroenterol Res Pract; 2014; 2014():529314. PubMed ID: 25165471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.
    Liu HF; Zou LQ; Lu XR; Sheng Y; Wang Q; Ding JL; Shi L; Liu SQ; Xing W
    J Magn Reson Imaging; 2020 Oct; 52(4):1019-1028. PubMed ID: 31675170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of cancer ratio for malignant pleural effusion: a systematic review and meta-analysis.
    Han YQ; Zhang L; Yan L; Ouyang PH; Li P; Hu ZD
    Ann Transl Med; 2019 Oct; 7(20):554. PubMed ID: 31807535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.